טוען...
Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells
Colorectal cancer (CRC) is a common and life-threatening type of malignant cancer, which is associated with a high mortality rate. Cisplatin (CDDP) is a commonly used chemotherapy drug with significant side effects. Brusatol (BR) is one of the principal chemical compounds isolated from the Chinese h...
שמור ב:
| הוצא לאור ב: | Int J Mol Med |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
D.A. Spandidos
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5819912/ https://ncbi.nlm.nih.gov/pubmed/29328398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.3372 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|